ArticleBMC cardiovascular disorders2026
Chronic kidney disease related mortality trends with and without valvular heart disease among adults in the United States: A retrospective analysis.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic kidney disease (CKD) and valvular heart disease (VHD) represent a significant global public health challenge. CKD is a major, independent risk factor for the development and progression of VHD. We aimed to examine the long-term mortality trends associated with VHD in individuals with and without CKD in the United States.
methodsWe obtained death certificate data for individuals aged ≥ 25 from the CDC WONDER, identifying deaths with VHD (International Classification of Diseases, 10th Revision [ICD-10] codes I05-I08) and CKD (ICD-10 N18). We calculated age-adjusted mortality rates (AAMRs) and crude mortality rates per 100,000 people. Annual percentage changes (APCs), average APC, and average differences in APCs through Joinpoint Regression.
resultsFrom 1999 to 2023, Concurrent VHD and CKD were attributed with 71,412 fatalities. AAMR rose from 0.81 in 1999 to 1.62 in 2023, reflecting an overall AAPC of 3.22 (95% CI: 2.20-4.26; p < 0.001). Males consistently exhibited higher AAMRs compared to females, but females showed a steeper rise (AAPC: 3.31 vs. 2.94). The highest AAMR was noted among non-Hispanic (NH) Black or African American individuals with an AAPC of 1.48. Mortality rates were elevated in the Midwest and among rural demographics when contrasted with urban populations. Mortality trends for concurrent VHD and CKD surpassed those for VHD or CKD alone.
conclusionImportantly, the increase in mortality associated with concurrent VHD and CKD occurred at a faster rate than that of VHD alone or CKD alone. These findings underscore the need for targeted interventions to address these disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.